Pulse on policy. Key issues emerge surrounding pharmaceutical pricing: consumer groups and politicians keep a close watch on drug prices and discounts, and on PBM Medicare pharmacy cards.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2004 AND VI 39 AND IP 7
Results: 25
1
2
Calcium and phosphorus management in chronic kidney disease: challenges and trends.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
3
Focus on... IV esomeprazole: a new proton pump inhibitor formulation.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
4
Agents for Alzheimer's disease and related disorders.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 372
- Publication type:
- Article
5
Key issues emerge surrounding pharmaceutical pricing.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 370
- By:
- Publication type:
- Article
6
Incremental tier systems increase member access with less financial exposure for health plans.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 369
- By:
- Publication type:
- Article
7
Drug and Formulary Trends.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 366
- Publication type:
- Article
8
Calcium and phosphorus management in chronic kidney disease: Challenges and trends.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 358
- By:
- Publication type:
- Article
9
Pharmacoeconomic analysis of oral triptans.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 356
- By:
- Publication type:
- Article
10
IV esomeprazole.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 349
- By:
- Publication type:
- Article
11
Estrogen/progestin linked with more severe colorectal cancer.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 347
- Publication type:
- Article
12
Statin therapy should be considered for all patients with type 2 diabetes.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 346
- Publication type:
- Article
13
Insulin sensitizer has favorable effects on blood pressure, lipids.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 346
- Publication type:
- Article
14
Incretin mimetics improve glycemic control in type 2 diabetes.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 344
- Publication type:
- Article
15
Normal liver enzymes no reason to withhold antiviral therapy for chronic HCV.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 343
- Publication type:
- Article
16
Statin use demonstrates benefits 3 months post-stroke.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 343
- Publication type:
- Article
17
Novel antibiotic may prevent travelers' diarrhea.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 342
- Publication type:
- Article
18
Rofecoxib use increases congestive heart failure risk compared to celecoxib and nonselective NSAIDs.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 341
- Publication type:
- Article
19
TNF inhibitor use associated with granulomatous infectious disease; infliximab poses greatest risk.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 341
- Publication type:
- Article
20
FDA actions in brief.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 340
- Publication type:
- Article
21
First-time generic approvals.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 340
- Publication type:
- Article
22
Peginterferon alfa-2a monotherapy more effective than lamivudine in treatment of chronic hepatitis B.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 342
- Publication type:
- Article
23
Pipeline preview.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 338
- Publication type:
- Article
24
Xifaxan.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 338
- Publication type:
- Article
25
Sanctura.
- Published in:
- Formulary, 2004, v. 39, n. 7, p. 338
- Publication type:
- Article